EU-funded Researchers Tackle Cervical Cancer

Cervical cancer is the second most common cancer worldwide; each year some 60,000 women in Europe alone are diagnosed with the disease, and around half of these cases will prove fatal.Supported by the EU with EUR 2.63 million in funding, the ASSIST project aimed to fix this problem by creating technological links between medical centres specialising in cervical cancer diagnosis and treatment, as well as fuelling data exchange and building a larger data repository.

While scientists accept that the human papillomavirus (HPV) is the central risk factor for cervical cancer, they also recognise that HPV is not the only culprit. Researchers have been assessing the role of specific genetic and environmental factors in determining HPV-persistence and the subsequent progression of disease. Past studies have hinted at pathogenetic mechanisms that could provide new markers of risk, diagnosis and prognosis and potentially lead to new targets for treatment.

The ASSIST (Association studies assisted by inference and semantic technologies) project set out to combine the different kinds of data gathered by the researchers; automate the process of evaluating medical hypotheses; provide an inference engine capable of assessing material statistically; bring together the patient records repositories of the participating institutions; and develop graphical, expressive tools for medical researchers to post their queries.

Medical researchers use association studies to identify common factors behind diseases. They assess clinical data from hospital tests, lifestyle data (e.g. smoking and eating habits) and genetic data. The researchers also compare data from patients with that of healthy patients.

"What we are trying to do is to allow medical researchers working in specialist hospitals and medical centres to use each others" data, and combine the data into a bigger pool to work with,' Professor Pericles Mitkas of the Centre for Research and Technology - Hellas, Informatics and Telematics Institute, Greece said. "The problem is, each hospital uses different formats, different rules for storing data, even for exactly the same tests,' the project coordinator said. 'Even within hospitals, each doctor might have his or her own way of doing things."

Professor Mitkas noted that to date the greatest achievement of ASSIST was strengthening the dialogue between medical doctors, molecular biologists and computer scientists. "They are talking to each other and finally understanding each others' technical language," he explained.

Three hospitals from Belgium, Germany and Greece took part in the first part of the project. After agreeing on the common terminology and how the data should be represented and accessed, the research team developed a prototype software platform that ensures researchers receive data that are in the format requested. "We do this by semantic representation, which means we assign an interpretation to each value to help the computer understand what each value refers to," the project leader said.

"We also facilitate interpretation of subjective values like 'high risk' and 'low risk', 'serious cases' and 'non-serious cases', and use inferencing techniques which are based on a set of medical rules provided by doctors to tell the computer which results are more valid than others," he said. "Biopsy results, for example, are more conclusive than Pap test results and may point to a pre-cancer stage that a Pap test did not reveal."

The ASSIST prototype platform gave researchers access to patients' records at the three hospitals' departments of gynaecology and obstetrics. "We add extra functionality as we go along, but at least the doctors now have something to work with and evaluate," Professor Mitkas said.

"Further down the line, understanding the path to the disease and the factors that affect it will help individual doctors diagnose it earlier, prevent it by giving directions to their patients, and develop drugs or procedures that will cure the disease," he said. "But ASSIST is primarily a tool for medical researchers, and the results of their research will benefit all women."

For further information, please visit:
http://assist.ee.auth.gr

Related article:

Copyright ©European Communities, 2009
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...